1. Home
  2. JBGS vs CBLL Comparison

JBGS vs CBLL Comparison

Compare JBGS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBG SMITH Properties

JBGS

JBG SMITH Properties

HOLD

Current Price

$12.29

Market Cap

823.7M

Sector

Real Estate

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

N/A

Current Price

$23.44

Market Cap

726.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
JBGS
CBLL
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
823.7M
726.2M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
JBGS
CBLL
Price
$12.29
$23.44
Analyst Decision
Sell
Strong Buy
Analyst Count
1
5
Target Price
$15.00
$23.20
AVG Volume (30 Days)
897.1K
397.3K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
56.93
EPS
N/A
N/A
Revenue
$498,598,000.00
$89,063,000.00
Revenue This Year
N/A
$29.57
Revenue Next Year
N/A
$28.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.09
52 Week Low
$10.77
$10.85
52 Week High
$24.30
$25.33

Technical Indicators

Market Signals
Indicator
JBGS
CBLL
Relative Strength Index (RSI) 45.86 65.90
Support Level $10.77 $16.70
Resistance Level $15.17 $24.64
Average True Range (ATR) 0.43 1.06
MACD 0.17 0.15
Stochastic Oscillator 86.00 74.33

Price Performance

Historical Comparison
JBGS
CBLL

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Share on Social Networks: